Overview

Targeted Chemo-elimination (TCE) of Malaria

Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The overall aim of this study is two fold: 1. to pilot targeted chemo-elimination of plasmodium falciparum malaria in known areas of artemisinin resistance in South East Asia. 2. to understand the micro-epidemiology of malaria in these areas; chiefly, the prevalence and importance to on-going transmission of sub-clinical p.f malaria infections.
Phase:
N/A
Details
Lead Sponsor:
University of Oxford
Collaborators:
Family Health International, Cambodia
FHI 360
Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit
Mahidol Oxford Tropical Medicine Research Unit
Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand
Myanmar Oxford Clinical Research Unit
Myanmar Oxford Clinical Research Unit (MOCRU), Myanmar
National Centre for Parasitology, Entomology and Malaria Control, Cambodia
National Malaria Control Program, Myanmar
National Malaria Control Program, Vietnam
Oxford University Clinical Research Unit (OUCRU), Vietnam
Oxford University Clinical Research Unit, Vietnam
Shoklo Malaria Research Unit
Shoklo Malaria Research Unit (SMRU), Thailand
Treatments:
Artemisinine
Artemisinins
Artenimol
Dihydroartemisinin
Piperaquine
Primaquine